Stay updated on ARO-APOC3 in FCS Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in FCS Clinical Trial page.

Latest updates to the ARO-APOC3 in FCS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe ClinicalTrials.gov page now displays the PALISADE study record for plozasiran, including its eligibility criteria, study design, outcomes, locations, and documents, instead of a 403 error.SummaryDifference84%

- Check20 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error page; its footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces an NIH terminology transition and links to updates and FAQs. The study record area continues to display a 403 error.SummaryDifference1%

- Check34 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedThe study record page displays a 403 Forbidden message instead of its study content, with a Home link.SummaryDifference0.5%

Stay in the know with updates to ARO-APOC3 in FCS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in FCS Clinical Trial page.